Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs

Abstract

Resveratrol could be potentially administered as an adjuvant with r-tPA treatment, which extends the clinical therapeutic window of r-tPA, therefore improving the outcome of patients receiving late stroke treatment.